• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌的系统评价与荟萃分析:微卫星高频估计及错配修复缺陷肿瘤组织学特征分析

Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology.

作者信息

Pal Tuya, Permuth-Wey Jenny, Kumar Ambuj, Sellers Thomas A

机构信息

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.

出版信息

Clin Cancer Res. 2008 Nov 1;14(21):6847-54. doi: 10.1158/1078-0432.CCR-08-1387.

DOI:10.1158/1078-0432.CCR-08-1387
PMID:18980979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2655731/
Abstract

PURPOSE

A meta-analytic approach was used to estimate the frequency of: (a) microsatellite instability-high (MSI-H) phenotype in unselected ovarian cancers and (b) various histologic subtypes of mismatch repair (MMR)-deficient epithelial ovarian cancers.

METHODS

A systematic search of the Medline electronic database was conducted to identify articles published between January 1, 1966, and December 31, 2007, that examined MMR deficiency in ovarian cancers. Data were extracted on the study population, sample size, MSI-H frequency, and histology of MMR-deficient ovarian tumors.

RESULTS

The pooled proportion of MSI-H ovarian cancers was 0.12 [95% confidence interval (CI), 0.08-0.17] from 18 studies with 977 cases. The proportion of histologic subtypes in the pooled analysis from 15 studies with 159 cases was serous at 0.32 (95% CI, 0.20-0.44), mucinous at 0.19 (95% CI, 0.12-0.27), endometrioid at 0.29 (95% CI, 0.22-0.36), clear cell at 0.18 (95% CI, 0.09-0.28), and mixed at 0.24 (95% CI, 0.07-0.47). There was significant heterogeneity between studies.

CONCLUSIONS

The frequency of the MSI-H phenotype in unselected ovarian cancers approximates 12%. MMR-deficient ovarian cancers also seem to be characterized by an overrepresentation of nonserous histologic subtypes. Knowledge of histologic subtype may aid clinicians in identifying the relatively large proportion of ovarian cancers due to MMR defects; such knowledge has potential implications for medical management.

摘要

目的

采用荟萃分析方法估计:(a)未选择的卵巢癌中微卫星高度不稳定(MSI-H)表型的频率,以及(b)错配修复(MMR)缺陷型上皮性卵巢癌的各种组织学亚型的频率。

方法

对Medline电子数据库进行系统检索,以识别1966年1月1日至2007年12月31日期间发表的研究卵巢癌中MMR缺陷的文章。提取有关研究人群、样本量、MSI-H频率以及MMR缺陷型卵巢肿瘤组织学的数据。

结果

来自18项研究共977例病例的汇总分析显示,MSI-H卵巢癌的合并比例为0.12[95%置信区间(CI),0.08 - 0.17]。来自15项研究共159例病例的汇总分析中,组织学亚型的比例为:浆液性0.32(95%CI,0.20 - 0.44),黏液性0.19(95%CI,0.12 - 0.27),子宫内膜样0.29(95%CI,0.22 - 0.36),透明细胞0.18(95%CI,0.09 - 0.28),混合型0.24(95%CI,0.07 - 0.47)。研究之间存在显著异质性。

结论

未选择的卵巢癌中MSI-H表型的频率约为12%。MMR缺陷型卵巢癌似乎也以非浆液性组织学亚型的比例过高为特征。了解组织学亚型可能有助于临床医生识别因MMR缺陷导致的相对较大比例的卵巢癌;此类知识对医疗管理具有潜在意义。

相似文献

1
Systematic review and meta-analysis of ovarian cancers: estimation of microsatellite-high frequency and characterization of mismatch repair deficient tumor histology.卵巢癌的系统评价与荟萃分析:微卫星高频估计及错配修复缺陷肿瘤组织学特征分析
Clin Cancer Res. 2008 Nov 1;14(21):6847-54. doi: 10.1158/1078-0432.CCR-08-1387.
2
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.结直肠癌患者林奇综合征的分子检测:系统评价和经济评估。
Health Technol Assess. 2017 Sep;21(51):1-238. doi: 10.3310/hta21510.
3
Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancer.错配修复缺陷系统/微卫星高度不稳定型结直肠癌患者的第二原发性恶性肿瘤
Therap Adv Gastroenterol. 2025 Jun 21;18:17562848251347375. doi: 10.1177/17562848251347375. eCollection 2025.
4
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.基于微卫星不稳定性状态的早期和晚期结直肠癌的传播率和预后:系统评价和荟萃分析。
Int J Colorectal Dis. 2021 Aug;36(8):1573-1596. doi: 10.1007/s00384-021-03874-1. Epub 2021 Feb 18.
7
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
10
Platinum-containing regimens for metastatic breast cancer.转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2017 Jun 23;6(6):CD003374. doi: 10.1002/14651858.CD003374.pub4.

引用本文的文献

1
Targeting the Werner syndrome protein in microsatellite instability cancers: mechanisms and therapeutic potential.靶向微卫星不稳定癌症中的沃纳综合征蛋白:机制与治疗潜力
Clin Exp Med. 2025 Aug 6;25(1):278. doi: 10.1007/s10238-025-01781-1.
2
Successful Conversion Surgery for Unresectable Microsatellite Instability-High Pancreatic Tail Cancer Following Pembrolizumab Therapy.帕博利珠单抗治疗后不可切除的微卫星高度不稳定型胰尾癌的成功转化手术
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0174. Epub 2025 Jul 2.
3
Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline pathogenic variant related colorectal cancer.用于预防与MSH6种系致病变异相关的结直肠癌的单基因疾病植入前基因检测。
BMC Cancer. 2025 Jul 1;25(1):1131. doi: 10.1186/s12885-025-14226-5.
4
Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors.实体瘤中的错配修复缺陷与微卫星不稳定性
Int J Mol Sci. 2025 May 6;26(9):4394. doi: 10.3390/ijms26094394.
5
Werner helicase as a therapeutic target in mismatch repair deficient colorectal cancer.沃纳解旋酶作为错配修复缺陷型结直肠癌的治疗靶点。
DNA Repair (Amst). 2025 May;149:103831. doi: 10.1016/j.dnarep.2025.103831. Epub 2025 Apr 3.
6
Cellular origins of mucinous ovarian carcinoma.黏液性卵巢癌的细胞起源
J Pathol. 2025 May;266(1):9-25. doi: 10.1002/path.6407. Epub 2025 Mar 3.
7
SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO.SKI复合物缺失使9p21.3缺失或微卫星高度不稳定(MSI-H)的癌症依赖于PELO。
Nature. 2025 Feb;638(8052):1104-1111. doi: 10.1038/s41586-024-08509-3. Epub 2025 Feb 5.
8
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors.DNA修复缺陷型肿瘤中同源重组(HR)与错配修复(MMR)途径的交叉。
NPJ Precis Oncol. 2024 Sep 5;8(1):190. doi: 10.1038/s41698-024-00672-0.
9
Genetic Links between Endometriosis and Endometriosis-Associated Ovarian Cancer-A Narrative Review (Endometriosis-Associated Cancer).子宫内膜异位症与子宫内膜异位症相关卵巢癌之间的遗传联系——一篇叙述性综述(子宫内膜异位症相关癌症)
Life (Basel). 2024 May 30;14(6):704. doi: 10.3390/life14060704.
10
Endometrioid ovarian carcinoma landscape: pathological and molecular characterization.子宫内膜样卵巢癌全景:病理和分子特征。
Mol Oncol. 2024 Oct;18(10):2586-2600. doi: 10.1002/1878-0261.13679. Epub 2024 Jun 25.

本文引用的文献

1
Ovarian endometrioma--risks factors of ovarian cancer development.卵巢子宫内膜异位囊肿——卵巢癌发生的危险因素
Eur J Obstet Gynecol Reprod Biol. 2008 Jun;138(2):187-93. doi: 10.1016/j.ejogrb.2007.06.017. Epub 2007 Dec 26.
2
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.加强流行病学观察性研究报告(STROBE):解释与详述
Epidemiology. 2007 Nov;18(6):805-35. doi: 10.1097/EDE.0b013e3181577511.
3
Risk factors for ovarian cancer histotypes.卵巢癌组织学类型的危险因素。
Eur J Cancer. 2007 May;43(7):1208-13. doi: 10.1016/j.ejca.2007.01.035. Epub 2007 Mar 21.
4
Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40.年轻女性的卵巢癌:基于人群的40岁以下上皮性卵巢癌系列中错配修复缺陷的作用。
Int J Gynecol Cancer. 2007 Jul-Aug;17(4):789-93. doi: 10.1111/j.1525-1438.2007.00875.x. Epub 2007 Mar 5.
5
The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer.化疗在微卫星高度不稳定(MSI-H)结直肠癌中的作用。
Int J Colorectal Dis. 2007 Jul;22(7):739-48. doi: 10.1007/s00384-006-0228-0. Epub 2006 Nov 16.
6
Immunohistochemical staining of hMLH1 and hMSH2 reflects microsatellite instability status in ovarian carcinoma.hMLH1和hMSH2的免疫组织化学染色反映了卵巢癌中的微卫星不稳定性状态。
Mod Pathol. 2006 Nov;19(11):1414-20. doi: 10.1038/modpathol.3800672. Epub 2006 Aug 25.
7
Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.子宫内膜异位症是卵巢癌前驱病变的分子遗传学证据。
Int J Cancer. 2006 Aug 1;119(3):556-62. doi: 10.1002/ijc.21845.
8
Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence.子宫内膜异位症与癌症之间的关联:临床和流行病学证据的全面综述与批判性分析。
Gynecol Oncol. 2006 May;101(2):331-41. doi: 10.1016/j.ygyno.2005.11.033. Epub 2006 Feb 13.
9
The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.遗传性非息肉病性结直肠癌综合征对卵巢癌发生发展的影响。
Gynecol Oncol. 2006 May;101(2):238-43. doi: 10.1016/j.ygyno.2005.10.029. Epub 2005 Dec 19.
10
Worldwide burden of gynaecological cancer: the size of the problem.全球妇科癌症负担:问题的规模
Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):207-25. doi: 10.1016/j.bpobgyn.2005.10.007. Epub 2005 Dec 13.